1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe V Foundation for Cancer Research Glioblastoma Grants is sponsored by The V Foundation for Cancer Research. The V Foundation funds innovative cancer research projects, including those focused on glioblastoma.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Our Cancer Research Grants | V Foundation Skip to content The Latest Brent Hall: Building a Legacy On and Off the Water Cancer Vaccine Coalition Commits $1 Million to Try to Stop Breast Cancer Recurrence—Before It Starts 5th Anniversary V Foundation for Cancer Research Sonoma Epicurean Raises $3.
5M to Fund Breakthrough Cancer Research Bill Dempsey: From the Operating Room to the Stands of Fenway Park Leadership & Collaboration Diversity, Equity and Inclusion The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded.
Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help men, women and children diagnosed with cancer. Reprogramming Differentiation Trajectories to Overcome FLT3 Inhibitor Resis...
Dissecting sensory nerve contributions in pancreatic inflammation and malig... Targeting Glutamine Metabolism in Soft Tissue Sarcoma Tumor-Infiltrating B Cells: Decoding Metabolic and Contact-Mediated Signals... A Data-Driven Approach to Uncover a Cysteine Sensor Regulating Cancer Ferro...
The systemic impact of breast cancer: understanding and reprogramming tumou... A New Metaplastic Cell Type in the Stomach: Elucidating the Triggers and Dr... Targeting histone acetyltransferase complexes in oncogenic fusion protein-d...
Overcoming Acquired Resistance to Antibody Drug Conjugate (ADC) Therapy in ... The role of tRNA cleavage by Angiogenin in controlling Kaposi sarcoma-assoc... Harnessing Commensal Microbes for Cancer Immunotherapy: Mechanism and Thera...
Targeting Obesity and Progesterone Resistance to Prevent Endometrial Cancer Systematic dissection of MECOM cofactor binding to identify druggable targe... Dual Targeting of Cancer Cells and Stromal Interactions in Lymphoma to Over... Developing tools to unlock the role of the pulmonary microbiome in lung cancer Paula Pohlmann, MD, MSc, PhD HER2 Vaccine Trial in Early Stage HER2 Positive Breast Cancer - INTERCEPT-HER2...
AKTing on DNA hypomethylation The Genomic Basis of Telomerase Inhibitor Sensitivity in Myelodysplastic Syndrome Patients The role of IL-1 crosstalk in pancreatic cancer-induced cachexia Restoring anti-tumor immunity in chromosomally unstable solid cancers PIK3CG as a novel target for tuft-like lung cancer Targeting unique residual disease biology to improve survival for patients with leukemia Natalie Silver, MD, MS, FACS Precision Immunotherapy to Reprogram the Tumor Immune Microenvironment in Anaplastic Thyroid Cancer Off-the-shelf HPV16 TCR engagers for adult HPV-driven cancers Topical Trametinib for HPV Precancer Interception: Optimizing Dose, Formulation, Schedule, PK, and...
Targeting CDK7 in Patients with Resectable or Borderline Resectable Basal-Like Pancreatic Ductal... Controlling treatment toxicity in ovarian cancer to prime the patient for tumor... Defining microbial control of immune recovery after cancer treatment A novel therapeutic strategy in AL amyloidosis and multiple myeloma: targeting immunoglobulin...
Stalling cancer at the ribosome Mechanisms of mutant ASXL1-driven clonal hematopoiesis and myeloid leukemia Statistics Statistics The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Marketing Marketing The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors Accept Deny View preferences Save preferences View preferences Statistics Statistics The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Marketing Marketing The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage {vendor_count} vendors Accept Deny View preferences Save preferences View preferences Manage consent Manage consent
According to the current listing, eligibility includes: Innovative researchers with cutting-edge ideas at state-of-the-art facilities. Confirm the full requirements in the official notice before applying.
The V Foundation for Cancer Research Glioblastoma Grants is funded by The V Foundation for Cancer Research. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article